Health
Trump signs order to stop funding for gain-of-function research believed to have caused COVID

From LifeSiteNews
Gain-of-function research, which involves purposefully making viruses more dangerous, was carried out at the Wuhan lab and is believed to be responsible for the COVID virus.
President Donald Trump on Monday signed an executive order ending federal funding for gain-of-function research – which intentionally makes viruses more dangerous or transmissible – in China and other countries.
As White House staff secretary Will Scharf noted, gain-of-function research is believed to be responsible for creating the COVID-19 virus, which originated from Wuhan, where U.S.-funded gain-of-function research has been conducted at the Wuhan Institute of Virology.
“It’s a big deal. It could have been that we wouldn’t have had the problem we had, if we had this done,” remarked Trump in reference to the COVID outbreak, before displaying the signed executive order in the Oval Office.
Trump signs Executive Order to end federal funding for gain-of-function virus research which many now believe caused the COVID pandemic. pic.twitter.com/mWKz2deuy3
— Paul D. Thacker (@thackerpd) May 5, 2025
As Conservative Treehouse has noted, gain-of-function research is essentially the “weaponization of biological agents.”
The U.S. Department of Health and Human Services (HHS) has claimed that the purpose of the dangerous experimentation is to “enabl[e] assessment of the pandemic potential of emerging infectious agents.”
The EO points out that unchecked gain-of-function research can lead to mass deaths, hinder the public health system, hurt livelihoods, and “diminis[h] economic and national security.” The order ends federal funding for gain-of-function research in China and other countries “where there is not adequate oversight” to ensure they comply with U.S. policy.
It also ends federal funding of “other life-science research” in countries without such sufficient oversight, “that could reasonably pose a threat to public health, public safety, and economic or national security[.]”
Director of National Intelligence Tulsi Gabbard recently acknowledged in an interview that gain-of-function research in the Wuhan lab was coordinated and funded by the U.S. government and noted that the intelligence community is close to drawing a direct connection between this research and the release of the COVID-19 virus.
In 2021, Fox News’ Steve Hilton released a report compiling evidence of this. It detailed how Dr. Anthony Fauci had signed off on a program that included gain-of-function work with coronaviruses at the Wuhan Institute of Virology.
In 2011, Fauci notably defended gain-of-function research in the Washington Post as “a risk a worth taking,” after more than 200 scientists called for a halt of gain-of-function trials with ferret viruses, citing the possibility of a deadly leak.
The White House and federal health officials temporarily banned funding or conducting gain-of-function activities in 2014, due to troubling incidents at U.S. laboratories, but the non-profit EcoHealth Alliance persisted in such research despite repeated warnings from National Institutes of Health (NIH) officials.
NIH officials repeatedly warned EcoHealth Alliance that its research violated the U.S. government “funding pause” on gain-of-function research, published emails have shown.
Nine hundred pages of documents obtained as part of a Freedom of Information Act litigation in 2021 confirmed that the NIH was supporting GOF research at the Wuhan Institute of Virology from at least 2014 to 2019, despite the repeated warnings from NIH officials.
Business
RFK Jr. planning new restrictions on drug advertising: report

Quick Hit:
The Trump administration is reportedly weighing new restrictions on pharmaceutical ads—an effort long backed by Health Secretary Robert F. Kennedy Jr. Proposals include stricter disclosure rules and ending tax breaks.
Key Details:
-
Two key proposals under review: requiring longer side-effect disclosures in TV ads and removing pharma’s tax deduction for ad spending.
-
In 2024, drug companies spent $10.8 billion on direct-to-consumer ads, with AbbVie and Pfizer among the top spenders.
-
RFK Jr. and HHS officials say the goal is to restore “rigorous oversight” over drug promotions, though no final decision has been made.
Diving Deeper:
According to a Bloomberg report, the Trump administration is advancing plans to rein in direct-to-consumer pharmaceutical advertising—a practice legal only in the U.S. and New Zealand. Rather than banning the ads outright, which could lead to lawsuits, officials are eyeing legal and financial hurdles to limit their spread. These include mandating extended disclosures of side effects and ending tax deductions for ad spending—two measures that could severely limit ad volume, especially on TV.
Health and Human Services Secretary Robert F. Kennedy Jr., who has long called for tougher restrictions on drug marketing, is closely aligned with the effort. “We are exploring ways to restore more rigorous oversight and improve the quality of information presented to American consumers,” said HHS spokesman Andrew Nixon in a written statement. Kennedy himself told Sen. Josh Hawley in May that an announcement on tax policy changes could come “within the next few weeks.”
The ad market at stake is enormous. Drugmakers spent $10.8 billion last year promoting treatments directly to consumers, per data from MediaRadar. AbbVie led the pack, shelling out $2 billion—largely to market its anti-inflammatory drugs Skyrizi and Rinvoq, which alone earned the company over $5 billion in Q1 of 2025.
AbbVie’s chief commercial officer Jeff Stewart admitted during a May conference that new restrictions could force the company to “pivot,” possibly by shifting marketing toward disease awareness campaigns or digital platforms.
Pharma’s deep roots in broadcast advertising—making up 59% of its ad spend in 2024—suggest the impact could be dramatic. That shift would mark a reversal of policy changes made in 1997, when the FDA relaxed requirements for side-effect disclosures, opening the floodgates for modern TV drug commercials.
Supporters of stricter oversight argue that U.S. drug consumption is inflated because of these ads, while critics warn of economic consequences. Jim Potter of the Coalition for Healthcare Communication noted that reinstating tougher ad rules could make broadcast placements “impractical.” Harvard professor Meredith Rosenthal agreed, adding that while ads sometimes encourage patients to seek care, they can also push costly brand-name drugs over generics.
Beyond disclosure rules, the administration is considering changes to the tax code—specifically eliminating the industry’s ability to write off advertising as a business expense. This idea was floated during talks over Trump’s original tax reform but was ultimately dropped from the final bill.
Alberta
Alberta pro-life group says health officials admit many babies are left to die after failed abortions

From LifeSiteNews
Alberta’s abortion policy allows babies to be killed with an ‘induced cardiac arrest’ before a late-term abortion and left to die without medical care if they survive.
A Canadian provincial pro-life advocacy group says health officials have admitted that many babies in the province of Alberta are indeed born alive after abortions and then left to die, and because of this are they are calling upon the province’s health minister to put an end to the practice.
Official data from the Canadian Institute for Health Information (CIHI), which is the federal agency in charge of reporting the nation’s health data, shows that in Alberta in 2023-2024, there were 133 late-term abortions. Of these, 28 babies were born alive after the abortion and left to die.
As noted by Prolife Alberta’s President Murray Ruhl in a recent email, this means the reality in the province is that “some of these babies are born alive… and left to die.”
“Babies born alive after failed late-term abortions are quietly abandoned—left without medical help, comfort, or even a chance to survive,” noted Ruhl.
This fact was brought to light in a recent opinion piece published in the Western Standard by Richard Dur, who serves as the executive director of Prolife Alberta.
Ruhl observed that Dur’s opinion piece has “got the attention of both Alberta Health Services (AHS) and Acute Care Alberta (ACA),” whom he said “confirmed many of the practices we exposed.”
Alberta’s policy when it comes to an abortion committed on a baby older than 21 weeks allows that all babies are killed before being born, however this does not always happen.
“In some circumstances… the patient and health practitioner may consider the option of induced fetal cardiac arrest prior to initiating the termination procedures,” notes Alberta Health Services’ Termination of Pregnancy, PS-92 (PS-92, Section 6.4).
Ruhl noted that, in Alberta, before an “abortion begins, they stop the baby’s heart. On purpose. Why? Because they don’t want a live birth. But sometimes—the child survives. And what then?”
When it comes to the same policy for babies older that 21 weeks, the policy states, “For terminations after 21 weeks and zero (0) days there must be careful consideration and documentation concerning a Do Not Resuscitate order in anticipation of a possible live birth.” (PS-92, Section 6.4).”
Ruhl observed that the reality is, “They plan in advance not to save her—even if she’s born alive.”
If the baby is born alive, the policy states, “Comfort measures and palliative care should be provided.” (PS-92, Section 6.4).
This means, however, that there is no oxygen given, no NICU, “no medical care,” noted Ruhl.
“Their policies call this ‘palliative care.’ We call it what it is: abandonment. Newborns deserve care—not a death sentence,” he noted.
As reported by LifeSiteNews recently, a total of 150 babies were born after botched abortions in 2023-2024 in Canada. However, it’s not known how many survived.
Only two federal parties in Canada, the People’s Party of Canada, and the Christian Heritage Party, have openly called for a ban on late abortions in the nation.
Policy now under ‘revision’ says Alberta Health Services
Ruhl said that the province’s policies are now “under revision,” according to AHS.
Because of this, Ruhl noted that now is the time to act and let the province’s Health Minister, Adriana LaGrange, who happens to be pro-life, act and “demand” from her real “action to protect babies born alive after failed abortions.”
The group is asking the province to do as follows below:
- Amend the AHS Termination of Pregnancy policy to require resuscitative care for any baby born with signs of life, regardless of how the birth occurred.
- Require that these newborns receive the same level of care as any other premature baby. Newborns deserve care—not a death sentence.
- Recognize that these babies have a future—there is a literal waiting list of hundreds of families ready to adopt them. There is a home for every one of them.
While many in the cabinet and caucus of Alberta Premier Danielle Smith’s United Conservative government are pro-life, she has still been relatively soft on social issues of importance to conservatives, such as abortion.
-
espionage2 days ago
From Sidewinder to P.E.I.: Are Canada’s Political Elites Benefiting from Beijing’s Real Estate Reach?
-
Business1 day ago
Senator wants to torpedo Canada’s oil and gas industry
-
Alberta2 days ago
Alberta’s carbon diet – how to lose megatonnes in just three short decades
-
Energy2 days ago
Who put the energy illiterate in charge?
-
espionage2 days ago
FBI Buried ‘Warning’ Intel on CCP Plot to Elect Biden Using TikTok, Fake IDs, CCP Sympathizers and PRC Students—Grassley Probes Withdrawal
-
David Clinton1 day ago
Why Are Ontario’s Public Schools So Violent?
-
Bruce Dowbiggin1 day ago
FUBAR: How Trudeau & Trump Rewrote This Century’s Political Handbook
-
Daily Caller2 days ago
Unanimous Supreme Court Ruling Inspires Hope For Future Energy Project Permitting